|
HHS Healthy Weight, Nutrition and Physical Activity Work Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK, NCI, NHLBI, NICHD, OD/DPCPSI/ODP
|
The Department of Health and Human Services (HHS) Healthy Weight, Nutrition and Physical Activity Work Group aims to improve dietary and physical activity behaviors through targeted sector initiatives.
|
|
HHS LGBT Policies Coordinating Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
OD/DPSCSI/SGMRO, NCCIH, NICHD, NIMH, NIMHD
|
The HHS LGBT Policy Coordinating Committee is comprised of senior representatives from each division of HHS. This committee coordinates LGBT-related policies across the department and recommends future actions that HHS can take to improve the health and well-being of LGBT individuals.
|
|
HHS Measurement Policy Council
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, SAMHSA
|
NLM
|
The HHS Measurement Policy Council was convened in early 2012 to begin the work of aligning measures across HHS. Composed of senior-level representatives from Agencies and operating divisions across HHS, the group also addresses new measure development and implementation, and measurement policy. The Council has so far reviewed nine topics to date: hypertension control, hospital-acquired conditions/patient safety, HCAHPs, smoking cessation, depression screening and care coordination, HIV/AIDS, perinatal, and obesity/BMI. While these measures are used for Federal programs, the Measurement Policy Council supports State and private-sector efforts to adopt core measure sets for further harmonization and alignment across the health and health care community. NLM serves on this council.
|
|
HHS Nutrition Policy Board
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
This Board coordinates the Department''s nutrition policy development and program implementation and is the principle point of contact with USDA for nutrition policy.
|
|
HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NICHD, NIAID, OD/DPCPSI/OAR
|
Also called ''Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection''. These updated Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection address the use of antiretroviral therapy (ART) for infants, children, and adolescents living with HIV. In general, these guidelines are appropriate for the care and management of youth with sexual maturity rating (SMR, formerly Tanner staging) I to III, whereas the guidelines developed by the Panel for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents are suitable for the care and management of adolescents in late puberty (SMR IV-V). Guidance on the management of adverse events associated with the use of antiretroviral (ARV) drugs in children and a detailed review of information about safety, efficacy, and pharmacokinetics (PK) of ARV agents in children is also included. The Department of Health and Human Services (HHS) Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV (the Panel), a working group of the Office of AIDS Research Advisory Council (OARAC), reviews new data on an ongoing basis and provides regular updates to the guidelines. The Guidelines are available on the AIDSinfo website at http://aidsinfo.nih.gov.
|
|
HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NICHD, NIAID, OD/DPCPSI/OAR
|
Also called ''Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States''. These Guidelines update the October 2016 Perinatal Guidelines. The Department of Health and Human Services Panel on Treatment of Pregnant Women Living with HIV and Prevention of Perinatal Transmission (the Panel), a working group of the Office of AIDS Research Advisory Council, develops these guidelines. The guidelines provide health care providers with information for discussion with pregnant women living with HIV infection to enable collaborative, informed decision-making regarding the use of ARV drugs during pregnancy, use of scheduled cesarean delivery to reduce perinatal transmission of HIV, and decision-making around the use of ARV drugs for prophylaxis of infants exposed to HIV. The recommendations in these Guidelines are accompanied by a discussion of various circumstances that commonly occur in clinical practice and the factors that influence treatment considerations. The Panel recognizes that strategies to prevent perinatal transmission and concepts related to management of HIV in pregnant women are rapidly evolving and will consider new evidence and adjust recommendations accordingly. The updated guidelines are available from the AIDSinfo website http://aidsinfo.nih.gov.
|
|
HHS Preparedness for Pregnant Women Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA, IHS, OS
|
NICHD, NIAID, NLM, OD/DPCPSI/ORWH
|
This HHS working group meets monthly to exchange information and consult on various agency programs related to preparedness for pregnant women.
|
|
HHS Secretary''s Initiative on Serious Mental Illness (SMI)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
The Department of Health and Human Services (HHS) Action Plan includes activities addressing the needs of individuals with serious mental illness (SMI) as well as those at high risk for developing SMI. This plan targets three goals: reducing the duration of untreated SMI through early engagement in care; improving the quality of care through stronger measurement and accountability; and increasing access to community-based treatment and support services.
|
|
HHS Sickle Cell Disease Interest Group
|
Other
|
CDC, CMS, HRSA, OS
|
NHLBI
|
The HHS Sickle Cell Disease Interest Group is a collaboration to discuss and share information on each agency''s SCD program to move the science forward.
|
|
HHS Tick-Borne Diseases Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NIAID
|
The Tick-Borne Disease Working Group was established by Congress in 2016 as part of the 21st Century Cures Act to provide subject matter expertise and to review federal efforts related to all tick-borne diseases, to help ensure interagency coordination and minimize overlap, and to examine research priorities. The focus of this effort is the development of a report to the Secretary of Health and Human Services and Congress on the findings and any recommendations of the Working Group for the federal response to tick-borne disease prevention, treatment, and research, as well as how to address gaps in these areas.
|